Experimental validation of absolute SPECT/CT quantification for response monitoring in patients with coronary artery disease

Alina van de Burgt*, Petra Dibbets-Schneider, Cornelis H. Slump, Arthur J.H.A. Scholte, Douwe E. Atsma, Lioe Fee de Geus-Oei, Floris H.P. van Velden

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Quantitative SPECT enables absolute quantification of uptake in perfusion defects. The aim of this experimental study is to assess quantitative accuracy and precision of a novel iterative reconstruction technique (Evolution; GE Healthcare) for the potential application of response monitoring using 99mTc-tetrofosmin SPECT/CT in patients with coronary artery disease (CAD).

Methods: Acquisitions of an anthropomorphic torso phantom with cardiac insert containing defects (with varying sizes), filled with 99mTc-pertechnetate, were performed on a SPECT/CT (Discovery 670 Pro, GE Healthcare). Subsequently, volumes of interest of the defects were manually drawn on CT to assess the recovery coefficient (RC). Bull’s eye plots were composed to evaluate the uptake per segment. Finally, 99mTc-tetrofosmin SPECT/CT scans of 10 CAD patients were used to illustrate clinical application.

Results: The phantom study indicated that Evolution showed convergence after 7 iterations and 10 subsets. The average repeatability deviation of all configurations was 2.91% and 3.15% (%SD mean) for filtered (Butterworth) and unfiltered data, respectively. The accuracy after post-filtering was lower compared to the unfiltered data with a mean (SD) RC of 0.63 (0.05) and 0.70 (0.07), respectively (p < 0.05). More artificial defects were found on Bull’s eye plots created with the unfiltered data compared to filtered data. Eight out of ten patients showed significant changes in uptake before and after treatment (p < 0.05).

Conclusion: Quantification of 99mTc-tetrofosmin SPECT/CT seems feasible for CAD patients when 7 iterations (10 subsets), Butterworth post-filtering (cut off frequency 0.52 in cycles/cm, order of 5) and manual CT-delineation are applied. However, future prospective patient studies are required for clinical application.

Original languageEnglish
Article number48
JournalEJNMMI physics
Volume8
Issue number1
DOIs
Publication statusPublished - Dec 2021

Keywords

  • Tc-tetrofosmin
  • Coronary artery disease
  • Experimental validation
  • Phantom study
  • Quantitative SPECT
  • SPECT/CT

Fingerprint

Dive into the research topics of 'Experimental validation of absolute SPECT/CT quantification for response monitoring in patients with coronary artery disease'. Together they form a unique fingerprint.

Cite this